# Study of Inhaled RNS60 in Combination With Budesonide to Treat Mild to Moderate Asthma

> **NCT01511302** · PHASE1 · COMPLETED · sponsor: **Revalesio Corporation** · enrollment: 65 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** RNS60
- **DRUG:** Normal Saline
- **DRUG:** Budesonide

## Key facts

- **NCT ID:** NCT01511302
- **Lead sponsor:** Revalesio Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2013-04
- **Final completion:** 2013-05
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2014-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01511302

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01511302, "Study of Inhaled RNS60 in Combination With Budesonide to Treat Mild to Moderate Asthma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01511302. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*